Detrimental effects of peritoneal dialysis solutions upon in vivo and in situ exposed mesothelium

Peritoneal Dialysis International

Volumn 17, Issue SUPPL. 2, 1997, Pages

  Gotloib, Lazaro ^a   Shostak, Avshalom ^a   Wajsbrot, Valeri ^a  

^a HAEMEK MEDICAL CENTER   (Israel)

Author keywords

Exposed mesothelium; Peritoneal dialysis solutions

Indexed keywords

GLUCOSE; LACTIC ACID; PERITONEAL DIALYSIS FLUID;

CELL CULTURE; CELL DENSITY; CELL SURFACE; CELL VIABILITY; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; MESOTHELIUM; MESOTHELIUM CELL; MITOSIS RATE; MONOLAYER CULTURE; MULTINUCLEAR CELL; PERITONEAL DIALYSIS; PH; PRIORITY JOURNAL; ULTRASTRUCTURE;

EID: 0030859552     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089701702s03     Document Type: Conference Paper

References (38)

1. Cannon WB. The Wisdom of the Body. London: Kegan Paul and Company, 1932.
2. Dobbie JM, Zaki M, Wilson L. Ultrastructural studies of the peritoneum with special reference to chronic ambulatory peritoneal dialysis. Scott Med 1981;26: 213-23.
3. Verger C, Brunschvicg O, Le Charpentier Y, Lavergne A, Vantelon J. Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis. Proc EDTA 1981; 18:199-205.
4. DiPaolo N, Sacchi G, De Mia M, et al. Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 1986; 44:204-11.
5. Gotloib L, Shostak A, Bar-Sella P, Cohen R. Continuous mesothelial injury and regeneration during long-term peritoneal dialysis. Perit Dial Bull 1987; 7:148-55.
6. Duwe AK, Vas SI, Weatherhead JW. Effects of the composition of peritoneal dialysis fluid on chemiluminiscence, phagocytosis, and bactericidal activity in vitro. Infect Immun 1981; 33:130-5.
7. Gagnon RF, Obst G, Richards GK, Gervais F. Effect of drug additives to peritoneal dialysis solutions on the viability and function of mouse peritoneal cells. Nephron 1990; 56:201-5.
8. Van Bronswijk H, Verbrough MA, Bos HJ, et al. Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro. Perit Dial Int 1989; 9:197-202.
9. Topley N, Mackenzie R, Petersen MM, et al. In vitro testing of a potentially biocompatible continuous ambulatory peritoneal dialysis fluid. Nephrol Dial Transplant 1991; 6:574-81.
10. Witowski J, Topley N, Jörres A, Liberek T, Coles GA, Williams JD. Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Kidney Int 1995; 47:282-93.
11. Breborowicz A. In vitro study on the biocompatibility of the peritoneal dialysis solution. Perit Dial Int 1992; 13 (Suppl 2):S105-8.
12. Breborowicz A, Rodela H, Martis L, Oreopoulos DG. Lactate at acid pH is responsible for the decrease in intracellular glutathione (GSH) of mesothelial cells (MC) exposed to dialysis solutions. Perit Dial Int 1995; 15 (Suppl 1):S68.
13. Shostak A, Pivnik E, Gotloib L. Cultured rat mesothelial cells generate hydrogen peroxide. A new player in peritoneal defense? J Am Soc Neph. In press.
14. Topley N, Kaur D, Petersen MM, et al. In vitro effect of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function. J Am Soc Neph 1996; 7:218-24.
15. Chaimovitz C, Rapaport J, Konforti J, Douvdevani A. Commercial dialysis fluid causes intracellular acidosis in peritoneal macrophages. J Am Soc Neph 1992; 3:407-12.
16. Kristensen SR, Pedersen FB. Cytotoxicity testing of two CAPD fluids in a model system of quiescent fibroblasts. Nephrol Dial Transplant 1993; 8:163-7.
17. Douvdevani A, Rapaort J, Konforti A, Zlotnik M, Chaimovitz C. The effect of peritoneal dialysis fluid on the release of IL-1 beta and TNF-alpha by macrophages/ monocytes. Perit Dial Int 1993; 13:112-7.
18. Liberek T, Topley N, Jörres A, Coles GA, Gahl GM, Williams JD. Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration. J Am Soc Neph 1993; 3:1508-15.
19. Jörres A, Jörres D, Gahl GM, et al. Leukotrienne B4 and tumor necrosis factor release from leukocytes: effect of peritoneal dialysate. Nephron 1991; 58:276-82.
20. Breborowicz A, Rodela H, Oreopoulos DG. Toxicity of osmotic solutes on human mesothelial cells in vitro. Kidney Int 1992; 41:1280-5.
21. Kumano K, Schiller-Moran B, Hjelle JT, Moran J. Hypertonic glucose decreases total protein synthesis but increases fibronectin (FN) gene expression on cultured rat mesothelial cells (RMC). Perit Dial Int 1994; 14(Suppl 1):S5.
22. Di Paolo N, Garosi G, Petrini G, Monaci G. Morphological and morphometric changes in mesothelial cells during peritoneal dialysis in the rabbit. Nephron 1996; 74:594-9.
23. Martinson E, Wieslander A, Kjellstrand P, Boberg V. Toxicity of heat sterilized peritoneal dialysis fluids is derived from the degradation of glucose. ASAIO 1992; 38:M370-2.
24. Efskind L. Experimentelle Untersuchungen uber die biologie desperitoneums. I. Die morphologische reaktion des peritoneums auf reize. Oslo: DetMorske Videnskaps Akademii, 1940.
25. Gotloib L, Shostak A, Wajsbrot V, Kushnier R. Biocompatibility of dialysis solutions evaluated by histochemical techniques applied to mesothelial cell imprints. Perit Dial Int 1993; 13 (Suppl 2):S113-5.
26. Gotloib L, Shostak A. Large mesothelial cells in peritoneal dialysis: a sign of degeneration or adaptation? Perit Dial Int 1996; 16:118-20.
27. Gotloib L, Wajsbrot V, Shostak A, Kushnier R. Acute and long term changes observed in imprints of mice mesothelium exposed to glucose enriched, lactated buffered dialysis solutions. Nephron 1995; 70:466-77.
28. Nolph KD, Twardowski ZI, Popovich RP, Rubin J. Equilibration of peritoneal dialysis solutions during long dwell exchanges. J Lab Clin Med 1979; 93:246-56.
29. Gotloib L, Wajsbrot V, Shostak A, Kushnier R. Population analysis of mesothelium, in-situ and in-vivo exposed to bicarbonate buffered peritoneal dialysis fluid. Nephron 1996; 73:219-27.
30. Rose BD. Clinical physiology of acid-base and electrolyte disorders. New York: McGraw Hill, 1994:297.
31. Stout RW. Glucose inhibits replication of cultured human endothelial cells. Diabetologia 1982; 23:436-9.
32. Lorenzi M, Nordberg JA, Toledo S. High glucose prolongs cell-cycle traversal of cultured human endothelial cells. Diabetes 1987; 36:1261-7.
33. Morocutti A, Earle KA, Sethi M, et al. Premature senescence of skin fibroblasts from insulin-dependent diabetic patients with kidney disease. Kidney Int 1996; 50:250-6.
34. Lorenzi M, Gagliero E, Toledo S. Glucose toxicity for human endothelial cells in culture. Diabetes 1985; 34:621-7.
35. Gotloib L, Shostak A. Endocytosis and transeytosis of albumin gold through mice peritoneal mesothelium. Kidney Int 1995; 47:1274-84.
36. Witowski J, Topley N, Jörres A, Liberek T, Coles GA, Williams JD. Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Kidney Int 1994; 46:282-93.
37. Muijsken MA, Heezius HJ, Verhoef J, Verbrugh HA. Role of mesothelial cells in peritoneal antibacterial defense. J Clin Pathol 1991; 44:600-4.
38. Vanholder R, Lameire N, Waterlocs MA, et al. Disturbed host defense in peritoneal cavity during CAPD: characterization dialysis of responsible factors in dwell fluid. Kidney Int 1996; 50:643-52.